Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Star Lake Bioscience CoSHSE:600866 -0.60%70 OCF Yield % is 1.83 as of Jul. 17, 2026, which is 65% below its 10-year median of 5.19. GuruFocus rates SHSE:600866 with a GF Score™ of 70/100 and a GF Value™ of ¥5.86 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 1,410 Biotechnology companies, Star Lake Bioscience Co ranks better than 83.26% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Star Lake Bioscience Co OCF Yield % Related Terms
Star Lake Bioscience Co OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:600866 vs VRTX, REGN, ALNY: OCF Yield % Comparison
For the Biotechnology subindustry, Star Lake Bioscience Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Star Lake Bioscience Co OCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Star Lake Bioscience Co's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Star Lake Bioscience Co's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Star Lake Bioscience Co (SHSE:600866) has a OCF Yield % of 1.83 as of Jul. 17, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Star Lake Bioscience Co and its competitors. This is 65% below median its historical median of 5.19. Over the past decade, Star Lake Bioscience Co's OCF Yield % has ranged from 0.06 to 36.26. According to the industry distribution chart, Star Lake Bioscience Co ranks #236 out of 1410 companies in the Biotechnology industry, placing it in the top 16.7%.
Is Star Lake Bioscience Co's OCF Yield % too high?
Star Lake Bioscience Co's current OCF Yield % of 1.83 is 65% below median its 10-year median of 5.19. Over the past 10 years, this metric has ranged from a low of 0.06 to a high of 36.26. Based on the distribution chart, Star Lake Bioscience Co ranks #236 out of 1410 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Star Lake Bioscience Co has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Star Lake Bioscience Co's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Star Lake Bioscience Co ranks #236 out of 1410 companies for OCF Yield %. This places Star Lake Bioscience Co in the top 17% of its industry — outperforming the majority of peers. Historically, Star Lake Bioscience Co's own OCF Yield % has ranged from 0.06 to 36.26 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Star Lake Bioscience Co and its competitors. Star Lake Bioscience Co's current OCF Yield % is 1.83, which is 65% below median its own 10-year median of 5.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Star Lake Bioscience Co stock overvalued right now?
Based on GuruFocus' analysis, Star Lake Bioscience Co (SHSE:600866) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥5.86, compared to a current price of ¥5.01 — trading 14.5% below its estimated fair value. The current OCF Yield % is 1.83, which is 65% below median its 10-year median of 5.19. Star Lake Bioscience Co's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Star Lake Bioscience Co (SHSE:600866), the current OCF Yield % is 1.83 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Star Lake Bioscience Co (SHSE:600866) Overvalued in 2026?
Based on GuruFocus' analysis, Star Lake Bioscience Co stock appears to be undervalued.
The current stock price of ¥5.01 is trading 14.5% below its estimated GF Value™ of ¥5.86.
GuruFocus considers Star Lake Bioscience Co to be Modestly Undervalued.
Key valuation signals for SHSE:600866:
OCF Yield %: 1.83 (65% below median its 10-year median of 5.19)
GF Value™: ¥5.86 vs. price of ¥5.01 (14.5% below fair value)
No single metric tells the full story. See the SHSE:600866 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.
70GF Score
Get the complete analysis for SHSE:600866
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600866 has been successfully added to your 
